Learn about Kim Herrity, melanoma survivor, and the Breakthrough Bike Challenge.

Recently, the FDA approved Azedra as the first-ever non-surgical treatment for rare neuroendocrine cancers, pheochromocytoma and paraganglioma. Learn how Penn Medicine helped bring the approval to fruition and how it may impact the future treatment of patients with rare cancers. 

If you're a cancer patient or survivor, consider trying practices like yoga to reaffirm your total sense of self and strengthen your body.

“I have my life back. I’ve had to make adjustments, but most importantly—thanks to my amazing care team at the Abramson Cancer Center and the help of my family—I can do the things I love. " — Paulette Whitekettle, sarcoma survivor

What causes pancreatic cancer? Why are the five-year survival rates low? How effective are treatment options? Oncologists and clinical researchers at Penn Medicine are working to answers these questions—and finding new ways of treating the disease.